JOHNSON & JOHNSON

JOHNSON & JOHNSON
World Rank (Jan-01-2021)
14
Market Value (Jan-01-2021)
414.310 Billion USD
World Rank (Jan-2020)
12
Market Value (Jan 1st 2020)
383.148 Billion USD
World Rank (July-04-2020)
11
Market Cap (July-04-2020):
371.646 Billion USD
World Rank (Aug-22-2020):
11
Market Cap (Aug-22-2020)
402.190 Billion USD
Stock Category
Dow Jones Index (DJIA)
S&P 500
Headquarters Country:
USA
Headquarters Region
New Jersey
Company Business
Healthcare
Medical Equipment
Pharmaceutical
FMCG
Biotechnology
Technology
HealthCare Products
Number of Employees
132,200
Employee Count as on Date
As on 2019
CEO:
Alex Gorsky
Founded Year
1886
Founders
James Wood Johnson
Robert Wood Johnson I
Edward Mead Johnson
Stock Exchange
NYSE
Yahoo @ NYSE
Wikipedia
Twitter
Facebook
Bloomberg
Company Website:
Johnson & Johnson - Top Consumer Goods, Pharmaceuticals, Medical Devices Company
Business Sector:
Top Technology Companies in USA
Top FMCG Companies in USA
Top Healthcare Companies in USA
Top Technology Companies in S&P 500
Top Healthcare Companies in S&P 500
Top Pharmaceutical Companies in USA
Top Pharmaceutical Companies in S&P 500
Annual Revenue
JOHNSON & JOHNSON Annual Revenues for December-2020 ending is 82.58 Billion USD
Annual Operating Income
19.73 Billion USD for Year ending December-2020
Annual Net Income
JOHNSON & JOHNSON Annual Net Income for December-2020 ending is 14.71 Billion USD
Total Current Assets
JOHNSON & JOHNSON Total Current Assets as on June-2020 is 45,892 Million USD
Total Assets
JOHNSON & JOHNSON Total Assets as on June-2020 is 158,380 Million USD
Total Current Liabilities
JOHNSON & JOHNSON Total Current Liabilities as on June-2020 is 36,772 Million USD
Total Liabilities
JOHNSON & JOHNSON Total Liabilities as on June-2020 is 95,402 Million USD
Total Equity
JOHNSON & JOHNSON Total Equity as on June-2020 is 62,978 Million USD
Short Term Debt
5,332 Million USD as on June-2020
Long Term Debt
25,062 Million USD as on June-2020
About Company Business:

Johnson & Johnson is USA based company and it manufactures Consumer Goods, Medical Devices and Equipment and Pharmaceutical Products. As on 2019, Johnson & Johnson has 132,200 employees across 60 countries. Headquarters is in USA.

As on December-2019, The Company’s subsidiaries operate 97 manufacturing facilities occupying approximately 15.2 million square feet of floor space for managing consumer goods, medical devices and pharmaceutical business segments.

Johnson & Johnson annual sales - segment wise in 2019

  • Consumer segment annual sales in 2019 were 14,053 Million USD.
  • Pharmaceutical segment annual sales in 2019 were 45,572 Million USD.
  • Medical Devices segment annual sales in 2019 were 22,959 Million USD.

Johnson & Johnson annual revenue generated for period ending Dec-2020 is 82.58 Billion USD.

Johnson & Johnson annual net income generated for period ending Dec-2020 is 14.71 Billion USD.

  • Johnson & Johnson Dec-2020 ending annual Revenues in USA 43,133 Million USD
  • Johnson & Johnson Dec-2020 ending annual Revenues outside USA is 39,451 Million USD

 

Annual Results Summary:

Johnson & Johnson - Annual Results Summary - in Billion USD:

ANNUAL RESULTS Revenue Operating Income Net Income EPS (USD)
Dec-2020 82.58 19.73 14.71 5.51
Dec-2019 82.05 20.08 15.12 5.63
Dec-2018 81.58 20.05 15.29 5.70
Dec-2017 76.45 18.71 1.30 0.48
Dec-2016 71.89   15.40 6.04
Dec-2015 70.07   15.41 5.57
Balance Sheet Summary

Johnson and Johnson - Balance Sheet Summary - in Million USD:

Year Ending: Total Current Assets Total Assets Total Current Liabilities Total Liabilities Total Equity
Dec-2020 51,237 174,894 42,493 111,616 63,278
Dec-2019 45,274 157,728 35,964 98,257 59,471
Dec-2018 46,033 152,954 31,230 93,202 59,752
Dec-2017 43,088 157,303 30,537 97,143 60,160
Jan-2017 65,032 141,208 26,287 70,790 70,418
Quarterly Results Summary:

Johnson and Johnson - Quarterly Results - Revenues and Profits - in Billion USD:

Quarter-Ending Revenue Net Profit EPS (USD)
Dec-2020 22.47 1.73 0.65
Sep-2020 21.08 3.55 2.20
Jun-2020 18.33 3.62 1.36
Mar-2020 20.68 5.80 2.20
Dec-2019 20.74 4.01 1.52
Sep-2019 20.73 4.83 1.83
Jun-2019 20.56 5.61 2.07
Mar-2019 20.02 3.75 1.39
Dec-2018 20.39 3.04 1.12
Sep-2018 20.35 3.93 1.44

 

Institutional Investors

Top 25 Institutional Investors in JOHNSON & JOHNSON as on Jun-30-2020

Rank OWNER NAME SHARES HELD CHANGE (SHARES) CHANGE (%) VALUE (IN 1,000S)
1 VANGUARD GROUP INC 231,747,508 -2,068,630 -0.89% $34,092,376
2 BLACKROCK INC. 193,714,044 1,168,129 0.61% $28,497,273
3 STATE STREET CORP 152,571,802 1,022,778 0.68% $22,444,838
4 GEODE CAPITAL MANAGEMENT, LLC 39,573,737 608,581 1.56% $5,821,692
5 BANK OF AMERICA CORP /DE/ 34,678,931 2,523,518 7.85% $5,101,618
6 STATE FARM MUTUAL AUTOMOBILE INSURANCE CO 34,574,792 0 0% $5,086,298
7 NORTHERN TRUST CORP 33,972,792 386,631 1.15% $4,997,737
8 BANK OF NEW YORK MELLON CORP 30,077,959 -1,719,123 -5.41% $4,424,769
9 MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 29,585,917 59,859 0.20% $4,352,384
10 WELLINGTON MANAGEMENT GROUP LLP 28,769,995 -1,786,667 -5.85% $4,232,354
11 NORGES BANK 28,375,314 18,223 0.06% $4,174,292
12 JPMORGAN CHASE & CO 23,182,854 108,133 0.47% $3,410,430
13 CAPITAL WORLD INVESTORS 23,112,974 1,916,985 9.04% $3,400,150
14 WELLS FARGO & COMPANY/MN 21,683,561 343,950 1.61% $3,189,869
15 MORGAN STANLEY 21,538,789 737,356 3.55% $3,168,571
16 AMERIPRISE FINANCIAL INC 19,118,078 1,712,137 9.84% $2,812,460
17 CAPITAL INTERNATIONAL INVESTORS 18,243,094 1,516,129 9.06% $2,683,742
18 LEGAL & GENERAL GROUP PLC 17,381,285 -290,479 -1.64% $2,556,961
19 NORDEA INVESTMENT MANAGEMENT AB 17,222,162 8,062,204 88.02% $2,533,552
20 PRICE T ROWE ASSOCIATES INC /MD/ 17,086,490 -1,914,763 -10.08% $2,513,594
21 CHARLES SCHWAB INVESTMENT MANAGEMENT INC 16,424,663 -145,704 -0.88% $2,416,232
22 FMR LLC 16,037,760 -1,105,456 -6.45% $2,359,315
23 NUVEEN ASSET MANAGEMENT, LLC 15,340,211 -453,360 -2.87% $2,256,698
24 ROYAL BANK OF CANADA 14,711,443 358,633 2.50% $2,164,200
25 DEUTSCHE BANK AG\ 14,134,825 -90,690 -0.64% $2,079,374

Comments

JOHNSON & JOHNSON Dec-2020 Ending Quarter (Q4) HIGHLIGHTS

  • 2020 Fourth-Quarter Sales of 22.5 Billion USD reflecting growth of 8.3%.
  • 2020 Fourth-Quarter Net Income of 1.73 Billion USD reflecting decline of 56.7%.

 

  • Johnson & Johnson Dec-2020 ending quarterly Revenues in USA 11,809 Million USD
  • Johnson & Johnson Dec-2020 ending quarterly Revenues outside USA is 10,666 Million USD
Sun, 31/01/2021 - 06:11

Share it on Social Media